MENOMUNE

This brand name is authorized in Singapore, South Africa

Active ingredients

The drug MENOMUNE contains a combination of these active pharmaceutical ingredients (APIs):

1 Meningococcal serogroup A polysaccharide vaccine UNII 1I86B47NY4 - NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN

Read about Meningococcal serogroup A polysaccharide vaccine

2 Meningococcal serogroup C polysaccharide vaccine UNII 9B7N7Y96MK - NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CRM-197 ADIPIC ACID CONJUGATE

Read about Meningococcal serogroup C polysaccharide vaccine

3 Meningococcal serogroup Y polysaccharide vaccine UNII CBZ4BH7TJ1 - NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN

Read about Meningococcal serogroup Y polysaccharide vaccine

4 Meningococcal serogroup W135 polysaccharide vaccine UNII 9F8QQ6EER1 - NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE ANTIGEN

Read about Meningococcal serogroup W135 polysaccharide vaccine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07AH04	Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AH Meningococcal vaccines
Discover more medicines within J07AH04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: SG	Health Sciences Authority	Identifier(s): 09948P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 38/30.1/0182